American Journal of Kidney Diseases
Volume 52, Issue 5 , Pages 876-886 , November 2008

Cross-sectional Association Between Fish Consumption and Albuminuria: The European Prospective Investigation of Cancer–Norfolk Study

  • Chee-Tin Christine Lee, MPhil

      Affiliations

    • Medical Research Council Epidemiology Unit, Cambridge, United Kingdom
    • ,
  • Amanda I. Adler, MD, PhD

      Affiliations

    • Medical Research Council Epidemiology Unit, Cambridge, United Kingdom
    • Corresponding Author InformationAddress correspondence to Amanda I. Adler, MD, PhD, MRC Epidemiology Unit, Institute of Metabolic Science, Addenbrooke's Hospital, Box 285, Cambridge, UK CB2 2QQ
    • ,
  • Nita G. Forouhi, MB, PhD

      Affiliations

    • Medical Research Council Epidemiology Unit, Cambridge, United Kingdom
    • ,
  • Robert Luben, BSc

      Affiliations

    • Department of Public Health and Primary Care, University of Cambridge, United Kingdom
    • ,
  • Ailsa Welch, PhD

      Affiliations

    • School of Medicine, Health Policy and Practice, University of East Anglia, Norwich, United Kingdom
    • ,
  • Kay-Tee Khaw, FRCP

      Affiliations

    • Department of Public Health and Primary Care, University of Cambridge, United Kingdom
    • ,
  • Sheila Bingham, PhD

      Affiliations

    • Department of Public Health and Primary Care, University of Cambridge, United Kingdom
    • ,
  • Nicholas J. Wareham, MB, PhD

      Affiliations

    • Medical Research Council Epidemiology Unit, Cambridge, United Kingdom

Received 2 December 2007 ,Accepted 29 February 2008.

References 

  1. Arnlov J, Evans JC, Meigs JB, et al. Low-grade albuminuria and incidence of cardiovascular disease events in nonhypertensive and nondiabetic individuals: The Framingham Heart Study. Circulation. 2005;112:969–975
  2. Iseki K, Ikemiya Y, Iseki C, Takishita S. Proteinuria and the risk of developing end-stage renal disease. Kidney Int. 2003;63:1468–1474
  3. Yuyun MF, Khaw KT, Luben R, et al. Microalbuminuria, cardiovascular risk factors and cardiovascular morbidity in a British population: The EPIC-Norfolk population-based study. Eur J Cardiovasc Prev Rehabil. 2004;11:207–213
  4. Hu FB, Cho E, Rexrode KM, Albert CM, Manson JE. Fish and long-chain w-3 fatty acid intake and risk of coronary heart disease and total mortality in diabetic women. Circulation. 2003;107:1852–1857
  5. Mollsten AV, Dahlquist GG, Stattin E, Rudberg S. Higher intakes of fish protein are related to a lower risk of microalbuminuria in young Swedish type 1 diabetic patients. Diabetes Care. 2001;24:805–810
  6. Sirtori CR, Crepaldi G, Manzato E, et al. One-year treatment with ethyl esters of n-3 fatty acids in patients with hypertriglyceridemia and glucose intolerance: Reduced triglyceridemia, total cholesterol and increased HDL-C without glycemic alterations. Atherosclerosis. 1998;137:419–427
  7. Petersen M, Pedersen H, Major-Pedersen A, Jensen T, Marckmann P. Effect of fish oil versus corn oil supplementation on LDL and HDL subclasses in type 2 diabetic patients. Diabetes Care. 2002;25:1704–1708
  8. Appel LJ, Miller ER, Seidler AJ, Whelton PK. Does supplementation of diet with ‘fish oil’ reduce blood pressure? (A meta-analysis of controlled clinical trials). Arch Intern Med. 1993;153:1429–1438
  9. Adler AI, Boyko EJ, Schraer CD, Murphy NJ. Lower prevalence of impaired glucose tolerance and diabetes associated with daily seal oil or salmon consumption among Alaska Natives. Diabetes Care. 1994;17:1498–1501
  10. Pedrini MT, Levey AS, Lau J, Chalmers TC, Wang PH. The effect of dietary protein restriction on the progression of diabetic and nondiabetic renal diseases: A meta-analysis. Ann Intern Med. 1996;124:627–632
  11. Teixeira SR, Tappenden KA, Carson L, et al. Isolated soy protein consumption reduces urinary albumin excretion and improves the serum lipid profile in men with type 2 diabetes mellitus and nephropathy. J Nutr. 2004;134:1874–1880
  12. De Mello V, Zelmanovitz T, Perassolo MS, Azevedo MJ, Gross JL. Withdrawal of red meat from the usual diet reduces albuminuria and improves serum fatty acid profile in type 2 diabetes with macroalbuminuria. Am J Clin Nutr. 2006;83:1032–1038
  13. Daviglus ML, Greenland P, Stamler J, et al. Relation of nutrient intake to microalbuminuria in nondiabetic middle-aged men and women: International Population Study on Macronutrients and Blood Pressure (INTERMAP). Am J Kidney Dis. 2005;45:256–266
  14. Riboli E, Kaaks R. The EPIC Project: Rationale and study design (European Prospective Investigation into Cancer and Nutrition). Int J Epidemiol. 1997;26(suppl 1):S6–S14
  15. Day N, Oakes S, Luben R, et al. EPIC-Norfolk: Study design and characteristics of the cohort. European Prospective Investigation of Cancer. Br J Cancer. 1999;80(suppl 1):S95–S103
  16. Willett WC, Sampson L, Stampfer MJ, et al. Reproducibility and validity of a semiquantitative food frequency questionnaire. Am J Epidemiol. 1985;122:51–65
  17. Welch AA, Luben R, Khaw KT, Bingham SA. The CAFÉ computer program for nutritional analysis of the EPIC-Norfolk food frequency questionnaire and identification of extreme nutrient values. J Hum Nutr Diet. 2005;18:99–116
  18. Bingham SA, Gill C, Welch A, et al. Validation of dietary assessment methods in the UK arm of EPIC using weighed records, and 24-hour urinary nitrogen and potassium and serum vitamin C and carotenoids as biomarkers. Int J Epidemiol. 1997;26(suppl 1):S137–S151
  19. Harding AH, Day NE, Khaw KT, et al. Habitual fish consumption and glycated haemoglobin: The EPIC-Norfolk study. Eur J Clin Nutr. 2004;58:277–284
  20. Zelmanovitz T, Gross JL, Oliveira JR, Paggi A, Tatsch M, de Azevedo MJ. The receiver operating characteristics curve in the evaluation of a random urine specimen as a screening test for diabetic nephropathy. Diabetes Care. 1997;20:516–519
  21. Yuyun MF, Khaw KT, Luben R, et al. Microalbuminuria independently predicts all-cause and cardiovascular mortality in a British population: The European Prospective Investigation into Cancer in Norfolk (EPIC-Norfolk) population study. Int J Epidemiol. 2004;33:189–198
  22. Lungershausen YK, Howe PR, Clifton PM, et al. Evaluation of an omega-3 fatty acid supplement in diabetics with microalbuminuria. Ann N Y Acad Sci. 1997;827:369–381
  23. Rossing P, Hansen BV, Nielsen FS, Myrup B, Holmer G, Parving HH. Fish oil in diabetic nephropathy. Diabetes Care. 1996;19:1214–1219
  24. Jensen T, Stender S, Goldstein K, Holmer G, Deckert T. Partial normalization by dietary cod-liver oil of increased microvascular albumin leakage in patients with insulin-dependent diabetes and albuminuria. N Engl J Med. 1989;321:1572–1577
  25. Shimizu H, Ohtani K, Tanaka Y, Sato N, Mori M, Shimomura Y. Long-term effect of eicosapentaenoic acid ethyl (EPA-E) on albuminuria of non-insulin-dependent diabetic patients. Diabetes Res Clin Pract. 1995;28:35–40
  26. Hamazaki T, Takazakura E, Osawa K, Urakaze M, Yano S. Reduction in microalbuminuria in diabetics by eicosapentaenoic acid ethyl ester. Lipids. 1990;9:541–545
  27. Mori TA, Bao DQ, Burke V, Puddey IB, Watts GF, Bellin LJ. Dietary fish as a major component of a weight loss diet: Effect on serum lipids, glucose, and insulin metabolism in overweight hypertensive subjects. Am J Clin Nutr. 1999;70:817–825
  28. Sugiyama S, Miyata T, Ueda Y, et al. Plasma levels of pentosidine in diabetic patients: An advanced glycation end product. J Am Soc Nephrol. 1998;9:1681–1688
  29. Ebbesson SO, Risica PM, Ebbesson LO, Kennish JM, Tejero ME. Omega-3 fatty acids improve glucose tolerance and components of the metabolic syndrome in Alaskan Eskimos: The Alaska Siberia project. Int J Circumpolar Health. 2005;64:396–408
  30. Retnakaran R, Cull CA, Thorne KI, Adler AI, Holman RR UKPDS Study Group. Risk factors for renal dysfunction in type 2 diabetes: U.K. Prospective Diabetes Study 74. Diabetes. 2006;55:1832–1839
  31. Ansquer JC, Foucher C, Rattier S, Taskinen MR, Steiner G DAIS Investigators. Fenofibrate reduces progression to microalbuminuria over 3 years in a placebo-controlled study in type 2 diabetes: Results from the Diabetes Atherosclerosis Intervention Study (DAIS). Am J Kidney Dis. 2005;43:485–493
  32. Keech A, Simes RJ, Barter P, et al. FIELD Study Investigators Effects of long-term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD study): Randomized controlled trial. Lancet. 2005;366:1849–1861
  33. Pecis M, de Azevedo MJ, Gross JL. Chicken and fish diet reduces glomerular hyperfiltration in IDDM patients. Diabetes Care. 1994;17:665–672
  34. Myint PK, Welch AA, Bingham SA, et al. Habitual fish consumption and risk of incident stroke: The European Prospective Investigation in Cancer (EPIC)-Norfolk prospective population study. Public Health Nutr. 2006;9:882–888
  35. Casas JP, Chua W, Loukogeorgakis S, et al. Effect of inhibitors of the renin-angiotensin system and other antihypertensive drugs on renal outcomes: Systematic review and meta-analysis. Lancet. 2005;366:2026–2033
  36. Heart Outcomes Prevention Evaluation Study Investigators. Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: Results of the HOPE study and MICRO-HOPE substudy. Lancet. 2000;355:253–259
  37. Welch AA, Bingham SA, Ive K, et al. Dietary fish intake and plasma phospholipid n-3 polyunsaturated fatty acid concentrations in men and women in the European Prospective Investigation into Cancer-Norfolk United Kingdom cohort. Am J Clin Nutr. 2006;84:1330–1339
  38. Mogensen CE, Vestbo E, Poulsen PL, et al. Microalbuminuria and potential confounders (A review and some observations on variability of urinary albumin excretion). Diabetes Care. 1995;18:572–581
  39. Schultz CJ, Dalton RN, Turner C, Neil HA, Dunger DB. Freezing method affects the concentration and variability of urine proteins and the interpretation of data on microalbuminuria (The Oxford Regional Prospective Study Group). Diabet Med. 2000;17:7–14
  40. Szklo M, Nieto FJ. Epidemiology—Beyond the Basics. (ed 2). Sudbury, MA: Jones & Bartlett; 2007;
  41. Jones CA, Francis ME, Eberhardt MS, et al. Microalbuminuria in the US population: Third National Health and Nutrition Examination Survey. Am J Kidney Dis. 2002;39:445–459
  42. Tarver-Carr ME, Powe NR, Eberhardt MS, et al. Excess risk of chronic kidney disease among African American versus white subjects in the United States: A population-based study of potential explanatory factors. J Am Soc Nephrol. 2002;13:2363–2370
  43. Tillin T, Forouhi N, McKeigue P, Chaturvedi N. Microalbuminuria and coronary heart disease risk in an ethnically diverse UK population: A prospective cohort study. J Am Soc Nephrol. 2005;16:3702–3710
  44. Young BA, Katon WJ, Von Korff M, et al. Racial and ethnic differences in microalbuminuria prevalence in a diabetes population: The Pathways Study. J Am Soc Nephrol. 2005;16:219–228
  45. Department of Health: Nutritional Aspects of Cardiovascular Disease. Report of the Cardiovascular Review Group Committee on Medical Aspects of Food and Nutrition Policy (Report on Health and Social Subjects No 46). London, UK: HMSO; 1994;
  46. Kris-Etherton PM, Harris WS, Appel LJ. Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease. Arterioscler Thromb Vasc Biol. 2003;23:e20–e30

 Originally published online as doi:10.1053/j.ajkd.2008.02.307 on June 4, 2008.

PII: S0272-6386(08)00579-9

doi: 10.1053/j.ajkd.2008.02.307

American Journal of Kidney Diseases
Volume 52, Issue 5 , Pages 876-886 , November 2008

Article Tools

* Image Usage & Resolution